Could a common cholesterol drug help slow liver failure?
NCT ID NCT06764966
First seen Mar 10, 2026 · Last updated May 13, 2026 · Updated 11 times
Summary
This study tests whether adding a statin (atorvastatin) to a standard beta-blocker can help people with decompensated cirrhosis, a serious form of liver disease. About 50 participants will receive either the combination or a beta-blocker plus placebo and be followed for 12 months. The goal is to see if the combination is safe and reduces complications like fluid buildup or bleeding.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Charleston Area Medical Center
RECRUITINGCharleston, West Virginia, 25304, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.